Chemoinformaics analysis of FORMIC ACID METHYL ESTER
| Molecular Weight | 60.052 | nRot | 1 |
| Heavy Atom Molecular Weight | 56.02 | nRig | 1 |
| Exact Molecular Weight | 60.0211 | nRing | 0 |
| Solubility: LogS | 0.737 | nHRing | 0 |
| Solubility: LogP | 0.027 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 8 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 4 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 4 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 2 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 7.61117 |
| nHD | 0 | BPOL | 6.61683 |
| QED | 0.391 |
| Synth | 2.949 |
| Natural Product Likeliness | 1.311 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.009 |
| HIA | 0.006 |
| CACO-2 | -4.426 |
| MDCK | 0.000921629 |
| BBB | 0.963 |
| PPB | 0.154135 |
| VDSS | 0.947 |
| FU | 0.811506 |
| CYP1A2-inh | 0.338 |
| CYP1A2-sub | 0.84 |
| CYP2c19-inh | 0.07 |
| CYP2c19-sub | 0.814 |
| CYP2c9-inh | 0.008 |
| CYP2c9-sub | 0.293 |
| CYP2d6-inh | 0.015 |
| CYP2d6-sub | 0.542 |
| CYP3a4-inh | 0.008 |
| CYP3a4-sub | 0.247 |
| CL | 7.417 |
| T12 | 0.868 |
| hERG | 0.008 |
| Ames | 0.018 |
| ROA | 0.727 |
| SkinSen | 0.254 |
| Carcinogencity | 0.077 |
| EI | 0.973 |
| Respiratory | 0.41 |
| NR-Aromatase | 0.004 |
| Antiviral | No |
| Prediction | 0.902667 |